1. Home
  2. DLNG vs RCEL Comparison

DLNG vs RCEL Comparison

Compare DLNG & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dynagas LNG Partners LP

DLNG

Dynagas LNG Partners LP

HOLD

Current Price

$3.80

Market Cap

142.3M

ML Signal

HOLD

Logo Avita Medical Inc.

RCEL

Avita Medical Inc.

HOLD

Current Price

$4.32

Market Cap

129.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DLNG
RCEL
Founded
2013
N/A
Country
Greece
United States
Employees
N/A
226
Industry
Marine Transportation
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
142.3M
129.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
DLNG
RCEL
Price
$3.80
$4.32
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$7.88
AVG Volume (30 Days)
50.5K
242.1K
Earning Date
05-26-2026
05-14-2026
Dividend Yield
5.18%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$17.17
Revenue Next Year
$1.10
$49.82
P/E Ratio
$3.04
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.40
$3.22
52 Week High
$4.45
$7.12

Technical Indicators

Market Signals
Indicator
DLNG
RCEL
Relative Strength Index (RSI) 42.86 48.11
Support Level $3.78 $4.00
Resistance Level $3.93 $4.57
Average True Range (ATR) 0.13 0.41
MACD 0.00 0.00
Stochastic Oscillator 34.62 22.16

Price Performance

Historical Comparison
DLNG
RCEL

About DLNG Dynagas LNG Partners LP

Dynagas LNG Partners LP is a limited partnership company focused on owning and operating high specification and versatile LNG carriers that are employed on multi-year contracts with international energy companies, providing the benefits of stable cash flows and high utilization rates. The company defines charters of two years or more as multi-year charters. Its current LNG Carrier fleet is optimized for trading flexibility. In addition to conventional trade, part of LNG Carrier fleet is assigned with Ice Class 1A FS notation and is winterized, which enables trade in subzero and ice bound conditions.

About RCEL Avita Medical Inc.

Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.

Share on Social Networks: